Cargando...
MNGI-06. EFFICACY OF (177)LU-DOTATATE THERAPY IN RECURRENT ANAPLASTIC MENINGIOMA
BACKGROUND: (177)Lu-Dotatate ((177)Lu-DOTA(0)-Tyr(3)-Octreotate) is a beta-particle emitting somatostatin analog recently FDA approved for the treatment of somastatin receptor-positive gastroenteropancreatic neuroendocrine tumors. Somatostatin receptors are highly expressed in almost all meningiomas...
Gardado en:
| Publicado en: | Neuro Oncol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Oxford University Press
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6846959/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.588 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|